Search results for "BRAF"

showing 10 items of 253 documents

PCSK9 Confers Inflammatory Properties to Extracellular Vesicles Released by Vascular Smooth Muscle Cells

2022

Vascular smooth muscle cells (VSMCs) are key participants in both early- and late-stage atherosclerosis and influence neighbouring cells possibly by means of bioactive molecules, some of which are packed into extracellular vesicles (EVs). Proprotein convertase subtilisin/kexin type 9 (PCSK9) is expressed and secreted by VSMCs. This study aimed to unravel the role of PCSK9 on VSMCs-derived EVs in terms of content and functionality. EVs were isolated from human VSMCs overexpressing human PCSK9 (VSMCPCSK9-EVs) and tested on endothelial cells, monocytes, macrophages and in a model of zebrafish embryos. Compared to EVs released from wild-type VSMCs, VSMCPCSK9-EVs caused a rise in the expression …

Myocytes Smooth MusclePCSK9; atherosclerosis; extracellular vesicles; inflammation; vascular smooth muscle cellsPCSK9; atherosclerosis; extracellular vesicles; inflammation; vascular smooth muscle cells.Muscle Smooth VascularCatalysisPCSK9Inorganic ChemistryExtracellular VesiclesSettore BIO/13 - Biologia ApplicataSettore MED/44 - Medicina del Lavorovascular smooth muscle cellsAnimalsHumansPhysical and Theoretical ChemistryMolecular BiologyZebrafishSpectroscopySettore MED/04 - Patologia GeneraleOrganic ChemistryEndothelial CellsGeneral MedicineComputer Science Applicationsinflammationextracellular vesicles; PCSK9; atherosclerosis; inflammation; vascular smooth muscle cellsSettore BIO/14 - FarmacologiaatherosclerosisProprotein Convertase 9International Journal of Molecular Sciences
researchProduct

Zebrafish Embryos Allow Prediction of Nanoparticle Circulation Times in Mice and Facilitate Quantification of Nanoparticle–Cell Interactions

2020

The zebrafish embryo is a vertebrate well suited for visualizing nanoparticles at high resolution in live animals. Its optical transparency and genetic versatility allow noninvasive, real-time observations of vascular flow of nanoparticles and their interactions with cells throughout the body. As a consequence, this system enables the acquisition of quantitative data that are difficult to obtain in rodents. Until now, a few studies using the zebrafish model have only described semiquantitative results on key nanoparticle parameters. Here, a MACRO dedicated to automated quantitative methods is described for analyzing important parameters of nanoparticle behavior, such as circulation time and…

NANOCARRIERSEmbryo Nonmammalianmiceanimal structurescirculation timeCellNanoparticleLIPOSOMES02 engineering and technology010402 general chemistry01 natural sciencesSEQUENCEBiomaterialsMiceDELIVERYmedicineMedicine and Health SciencesAnimalsGeneral Materials ScienceZebrafishZebrafishbiologyChemistryMacrophagesEndothelial CellsOptical transparencyPLGAGeneral ChemistryTARGETING MACROPHAGES021001 nanoscience & nanotechnologybiology.organism_classificationzebrafishCANCER0104 chemical sciencesCell biologymacrophagesChemistrymedicine.anatomical_structureCell cultureembryonic structuresZebrafish embryoNanoparticlesCirculation timenanoparticlesNanocarriers0210 nano-technologyANTIBIOTICSBiotechnology
researchProduct

Targeted sequencing of BRAF by MinION in archival Formalin-Fixed Paraffin-Embedded specimens allows to discriminate between Hairy Cell Leukemia and H…

2016

Targeted sequencing of BRAF by MinION in archival Formalin-Fixed Paraffin-Embedded specimens allows to discriminate between Hairy Cell Leukemia and Hair Cell Leukemia Variant

NanoporeNGSMinIONHairy Cell LeukemiaBRAF
researchProduct

Expression analysis of jagged genes in zebrafish embryos

2005

The interaction of transmembrane Delta and Jagged/Serrate ligands with Notch receptors on neighboring cells is critically involved in cell specification during development. In zebrafish, the early expression of delta but not of jagged genes has been investigated in some detail. We have analyzed the sequence and embryonic expression pattern of the three zebrafish genes jagged1a, jagged1b, and jagged2. These genes, whose transcripts are detectable by in situ hybridization from early somitogenesis, are widely and dynamically expressed in embryos. Coexpression is limited, however, to the notochord and lens (jagged1a and jagged1b) and to the otic vesicle and pronephros (jagged1b and jagged2). Co…

Nervous systemanimal structuresNotchNotch signaling pathwayNotochordBiologystomatognathic systemSomitogenesisNotochordmedicineAnimalsPancreaSerrate-Jagged ProteinsSomitePlacodeZebrafishPhylogenyNotch signalingZebrafishGeneticsVertebrateCalcium-Binding ProteinsGene Expression Regulation DevelopmentalMembrane ProteinsCell BiologyZebrafish Proteinsbiology.organism_classificationCell biologyPronephrosmedicine.anatomical_structurezebrafish; Notch; JaggedEmbryoIntercellular Signaling Peptides and ProteinsPronephroOtic vesicleJaggedJagged-2 ProteinOtic PlacodesDevelopmental biologyIn situ hybridizationJagged/serrate geneEmbryo; In situ hybridization; Jagged/serrate genes; Nervous system; Notch signaling; Notochord; Pancreas; Placodes; Pronephros; Somites; Vertebrate; Zebrafish; Developmental Biology; Cell BiologyDevelopmental Biology
researchProduct

Power-effective scanning with AODs for 3D optogenic applications

2022

Two-photon (2P) excitation is a cornerstone approach widely employed in neuroscience microscopy for deep optical access and sub-micrometric-resolution light targeting into the brain. However, besides structural and functional imaging, 2P optogenetic stimulations are less routinary, especially in 3D. This is because of the adopted scanning systems, often feebly effective, slow and mechanically constricted. Faster illumination can be achieved through acousto-optic deflectors (AODs) although their applicability to large volumes excitation has been limited by large efficiency drop along the optical axis. Here, we present a new AOD-based scheme for 2P 3D scanning that improves the power delivery…

Neuronsacousto-optic deflectorsGeneral EngineeringBrainGeneral Physics and AstronomyGeneral ChemistryTwo-photon (2P) excitationSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)Settore FIS/03 - Fisica Della MateriaGeneral Biochemistry Genetics and Molecular BiologyAnimalsGeneral Materials ScienceoptogeneticsAcousto-optic deflectors optogenics Two-photon excitationPhotic StimulationZebrafish
researchProduct

Comparison of testing acute toxicity on embryo of zebrafish, Brachydanio rerio and RTG-2 cytotoxicity as possible alternatives to the acute fish test

1995

Abstract The present study compares two possible alternative methods to replace the acute fish test. Fertilized eggs of zebrafish, Brachydanio rerio were used to investigate the acute toxicity of chemicals. Different toxicological endpoints such as coagulation of the eggs, development of gastrulation, number of somites, development of organs, circulation, heartbeat, otolithanlage and pigmentation have been examined during the embryonic development of zebrafish within the first 48 h. Differences to the normal development were measured by these endpoints. Chemicals have been examined in a preliminary approach with respect to their cytotoxicity on the RTG-2 cells (Rainbow Trout Gonad). The vit…

Neutral redanimal structuresEnvironmental EngineeringbiologyHealth Toxicology and MutagenesisEmbryogenesisPublic Health Environmental and Occupational HealthEmbryoGeneral MedicineGeneral Chemistrybiology.organism_classificationPollutionAcute toxicityToxicologyAndrologychemistry.chemical_compoundchemistryToxicityEnvironmental ChemistryMTT assayCytotoxicityZebrafishChemosphere
researchProduct

Addressing the importance of melanoma tumor‑infiltrating lymphocytes in disease progression and clinicopathological characteristics

2021

Tumor-infiltrating lymphocytes (TILs) in primary cutaneous melanoma are considered to represent the host's antitumor immunological response; however, whether there are associations between TIL grade and histopathological characteristics and disease survival remains controversial. BRAF mutational status has been established as a routine screening method in advanced malignant melanoma, and worse prognosis rates have been demonstrated in patients harboring BRAF mutations. However, the general impact of BRAF mutational status on survival and histopathological characteristics is still debated. The aim of the present study was to compare the value of the assessment of TIL grade in stages I-II nod…

OncologyCancer Researchmedicine.medical_specialtyTumor-infiltrating lymphocytesbusiness.industryMelanomaHazard ratioCancerBRAF V600ArticlesDiseasemedicine.diseaseSuperficial spreading melanomaOncologytumor infiltrating lymphocytesInternal medicineCutaneous melanomamelanomahistopathologymedicineStage (cooking)businessneoplasmsMolecular and Clinical Oncology
researchProduct

LGG-16. PREDICTORS OF OUTCOME IN BRAF-V600E PEDIATRIC GLIOMAS TREATED WITH BRAF INHIBITORS: A REPORT FROM THE PLGG TASKFORCE

2019

The BRAF-V600E mutation is found in 15–20% of pediatric low grade gliomas (PLGG) and result in worse outcome and higher risk of transformation to high grade gliomas (PHGG). Although ongoing trials are assessing the role of BRAF inhibitors (BRAFi) in these children, data are still limited. We aimed to report overall response rates and predictors of outcome in childhood BRAF-V600E gliomas. We collected clinical, imaging and molecular information of patients treated with BRAFi outside trials from centers participating in the PLGG taskforce. Response was calculated by RANO criteria and follow up data were collected for all patients. Sixty-six patients were treated with BRAFi (55 PLGG and 11 PHG…

OncologyCancer Researchmedicine.medical_specialtybusiness.industryLow Grade Gliomamedicine.diseaseChemotherapy regimenBRAF V600EOncologyInternal medicineGliomaMutation (genetic algorithm)MedicineLow-Grade GliomaNeurology (clinical)businessneoplasmsNeuro-Oncology
researchProduct

LGG-59. REMARKABLE OBJECTIVE RESPONSE AND FAVORABLE SURVIVAL FOR BRAF-V600E CHILDHOOD LOW-GRADE GLIOMAS TO BRAF INHIBITORS COMPARED CONVENTIONAL CHEM…

2018

Activation of the MAPK pathway represents a hallmark of pediatric low-grade glioma (pLGG) and is frequently caused by BRAF alterations. BRAF-V600E represent an aggressive type of pLGG with less than optimal response to conventional chemo-radiation approaches. While clinical trials using BRAF-V600E inhibitors are ongoing, these data are not yet available. We have assembled an international cohort of BRAF-V600E glioma patients treated off-label with BRAF inhibitors as a monotherapy. Complete molecular, clinical and imaging data is being collected and compared to previous chemo-radiation therapies. Ongoing data form the taskforce on 40 BRAF-V600E gliomas from 25 international institutions is s…

OncologyCancer Researchmedicine.medical_specialtyendocrine system diseasesbusiness.industrydigestive system diseasesBRAF V600EAbstractsOncologyInternal medicinemedicineConventional chemotherapyNeurology (clinical)businessneoplasmsObjective responseNeuro-Oncology
researchProduct

Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/Wo…

2010

The article summarizes the expert discussion and recommendations on the use of molecular markers and of biological targeted therapies in metastatic colorectal cancer (mCRC), as well as a proposed treatment decision strategy for mCRC treatment. The meeting was conducted during the 11th ESMO/World Gastrointestinal Cancer Congress (WGICC) in Barcelona in June 2009. The manuscript describes the outcome of an expert discussion leading to an expert recommendation. The increasing knowledge on clinical and molecular markers and the availability of biological targeted therapies have major implications in the optimal management in mCRC. 21 Suppl 6 vi1 10

OncologyColorectal cancermedicine.medical_treatmentBraf proteinGastroenterologyMetastasisDrug antagonismTargeted therapyMetastasisAntineoplastic agentsPathologyConference paperBiological markersPredictive markerHematologyPrognosisChemotherapy regimenAntineoplastic agentOncologyProto-oncogene proteinsRas proteinHumanReceptormedicine.medical_specialtyNeoplasm metastasisRas proteinsMEDLINEOncoproteinColorectal neoplasmsProto-oncogene proteins b-rafInternal medicineGeneticsmedicineHumansGastrointestinal cancerColorectal tumorB raf kinaseEpidermal growth factor receptorKras proteinbusiness.industryEpidermal growth factorCancermedicine.diseasedigestive system diseasesBiological markerMetabolismSpainMutationCarcinoembryonic antigenMicrosatellite instabilitybusinessAnnals of Oncology
researchProduct